Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism
Qiang Zhou, Yirui Yin, Mincheng Yu, et al.
Redox Biology (2022) Vol. 56, pp. 102458-102458
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 35
ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment
Juan Zhang, Fan Ouyang, Anbo Gao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Roles of protein post-translational modifications in glucose and lipid metabolism: mechanisms and perspectives
Yuhang Yang, Ri Wen, Ni Yang, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 32
Metabolic Signaling in Cancer Metastasis
Sarah Krieg, Sara Fernandes, Constantinos Kolliopoulos, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 934-952
Open Access | Times Cited: 12
Foot-and-mouth disease virus VP1 degrades YTHDF2 through autophagy to regulate IRF3 activity for viral replication
Huisheng Liu, Xue Qiao, Fan Yang, et al.
Autophagy (2024) Vol. 20, Iss. 7, pp. 1597-1615
Open Access | Times Cited: 8
Histone lactylation promotes multidrug resistance in hepatocellular carcinoma by forming a positive feedback loop with PTEN
Yuan Zeng, Haoran Jiang, Zhoufeng Chen, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Melatonin suppresses PD-L1 expression and exerts antitumor activity in hepatocellular carcinoma
Rui Guo, Visweswara Rao Pasupuleti, Bo Liao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al‐Hetty, Pushpamala Ramaiah, et al.
Environmental Research (2023) Vol. 227, pp. 115683-115683
Closed Access | Times Cited: 17
Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic Opportunities
Hengdong Qu, Junli Liu, Di Zhang, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1930-1930
Open Access | Times Cited: 16
Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
Zhao-Shan Niu, Wenhong Wang, Xiao-Jun Niu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6433-6477
Open Access | Times Cited: 20
Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review
Qi Wang, Juan Liu, Ziye Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116021-116021
Open Access | Times Cited: 11
Identification and validation of DHCR7 as a diagnostic biomarker involved in the proliferation and mitochondrial function of breast cancer
Yanfeng Wang, Jiaxin Fan, Yongcheng Liu, et al.
Aging (2024)
Open Access | Times Cited: 4
Research Progress of Warburg Effect in Hepatocellular Carcinoma
Yanguang Yang, Yuting Gao, Yajun Xiong, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 4
LncRNA‐Mediated TPI1 and PKM2 Promote Self‐Renewal and Chemoresistance in GBM
Changxiao Yang, Ziwei Li, Kaifu Tian, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications
Yingquan Liu, Peijia Hu, Hongliang Cheng, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy
Jiabin Liang, Jian Zhao, Lin Yang, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Role of Ubiquitination-driven Metabolisms in Oncogenesis and Cancer Therapy
Dongqin Yang, Can Yang, Linlin Huang, et al.
Seminars in Cancer Biology (2025)
Closed Access
Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Lactate promotes the epithelial-mesenchymal transition of liver cancer cells via TWIST1 lactylation
Huimin Wang, Xin Wu, Shan Yu, et al.
Experimental Cell Research (2025), pp. 114474-114474
Closed Access
Decoding the Molecular Landscape of Prepubertal Oocyte Maturation: GTPBP4 as a Key Driver of In Vitro Developmental Competence
Jianpeng Qin, Yaozong Wei, Ao Ning, et al.
Cell Proliferation (2025)
Open Access
Induction of Ferroptosis by Shikonin in Gastric Cancer via the DLEU1/mTOR/GPX4 Axis
Yiying Wang, Midie Xu, Cheng Liu, et al.
Cell Biology International (2025)
Closed Access
PKM2: A Potential Regulator of Cardiac Injury Through Glycolytic and Non-glycolytic Pathways
Chenxin Zeng, Jiang‐Feng Wu, Jun-ming Li
Journal of Cardiovascular Pharmacology (2024) Vol. 84, Iss. 1, pp. 1-9
Open Access | Times Cited: 3
SUMOylation at the crossroads of gut health: insights into physiology and pathology
XueNi Ma, Muyang Li, Guoqing Qi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3
Xue Qiao, Zixiang Zhu, Zhaoning Xue, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 7, pp. e1011511-e1011511
Open Access | Times Cited: 7
Abnormal protein SUMOylation in liver disease: novel target for therapy
Yanfang Yang, Fuxun Yu
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 719-731
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top